What question did this study set out to answer?

To investigate the role of right ventricular dysfunction in the context of cardiotoxicity related to bone marrow transplantation.

April 27, 2026

Right Ventricular Dysfunction in Bone Marrow Transplantation: An Emerging Component of Cancer Therapy–Related Cardiotoxicity

Key Result

Right ventricular dysfunction is an emerging component of cancer therapy-related cardiotoxicity in patients undergoing bone marrow transplantation.

Key Points

To investigate the role of right ventricular dysfunction in the context of cardiotoxicity related to bone marrow transplantation.
Review of existing literature regarding cardiac health post-bone marrow transplantation.
Analysis of mechanisms contributing to right ventricular dysfunction in cancer therapy.
Emerging evidence suggests a significant link between bone marrow transplantation and right ventricular dysfunction.
Cardiotoxicity rates may increase in patients undergoing cancer therapy, necessitating close cardiovascular monitoring.

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

The author declares no potential conflicts of interest related to this work. Data sharing is not applicable to this article as no new data were created or analyzed.

Bookmark

Cite This Study

Caroline O Fischer-Bacca (Sat,) reported a other. Right ventricular dysfunction is an emerging component of cancer therapy-related cardiotoxicity in patients undergoing bone marrow transplantation.

synapsesocial.com/papers/69eefd64fede9185760d40f2 https://doi.org/https://doi.org/10.1111/echo.70486